Current management and future challenges in salivary glands cancer
Frontiers in Oncology · 19.09.2023 · 13
DOI: 10.3389/fonc.2023.1264287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 19.09.2023. Verfasst von Laura D Locati und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Salivary gland cancers (SGCs) are rare, accounting for less than 5% of all malignancies of the head and neck region, and are morphologically heterogeneous. The diagnosis is mainly based on histology, with the complementary aid of molecular profiling, which is helpful in recognizing some poorly differentiated, borderline, or atypical lesions. Instrumental imaging defines the diagnosis, representing a remarkable tool in the treatment plan. Ultrasound and magnetic resonance are the most common procedures used to describe the primary tumour. The treatment of SGCs is multimodal and consists of surgery, radiotherapy, and systemic therapy; each treatment plan is, however, featured on the patient and disease’s characteristics. On 24 June 2022, in the meeting “Current management and future challenges in salivary gland cancers” many experts in this field discussed the state of the art of SGCs research, the future challenges and developments. After the meeting, the same pool of experts maintained close contact to keep these data further updated in the conference proceedings presented here. This review collects the insights and suggestions that emerged from the discussion during and after the meeting per se.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
- Medical Oncology Unit, Istituti Clinici Scientifici Maugeri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Pavia, Italy.
- Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
- Head and Neck Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) National Cancer Institute, Milano, Italy.
- University of Milan, Milano, Italy.
- Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
Zitieren
APA
Locati, L. D., Ferrarotto, R., Licitra, L., Benazzo, M., Preda, L., Farina, D., Gatta, G., Lombardi, D., Nicolai, P., Vander Poorten, V., Chua, M. L. K., Vischioni, B., Sanguineti, G., Morbini, P., Fonseca, I., Sozzi, D., Merlotti, A., & Orlandi, E. (2023). Current management and future challenges in salivary glands cancer. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1264287
Vancouver
Locati LD, Ferrarotto R, Licitra L, Benazzo M, Preda L, Farina D, et al. Current management and future challenges in salivary glands cancer. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1264287
BibTeX
@article{Locati2023,
author = {Locati, Laura D and Ferrarotto, Renata and Licitra, Lisa and Benazzo, Marco and Preda, Lorenzo and Farina, Davide and Gatta, Gemma and Lombardi, Davide and Nicolai, Piero and Vander Poorten, Vincent and Chua, Melvin Lee Kiang and Vischioni, Barbara and Sanguineti, Giuseppe and Morbini, Patrizia and Fonseca, Isabel and Sozzi, Davide and Merlotti, Anna and Orlandi, Ester},
title = {Current management and future challenges in salivary glands cancer},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1264287}
}
EUVIMED